// App-Quantinova.ai

: Haemostatic Biomarkers for Prediction of Therapy Response and Prognosis of Disease in Patients with Metastatic Colorectal Cancer

Researchers

Presenter

  • F. Moik

Principal Investigators

  • F. Posch

  • E. Grilz

  • W. Scheithauer

  • I. Pabinger

  • G. Prager

  • C. Ay

Medical Centers

  • Medical University of Vienna, Clinical Division of Haematology and Haemostaseology, Department of Internal Medicine I, Comprehensive Cancer Center, Vienna, Austria

  • Medical University of Graz, Division of Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Graz, Austria

  • Center for Biomarker Research in Medicine (CBmed), Graz, Austria

  • Medical University of Graz, Division of Oncology, Department of Internal Medicine, Comprehensive Cancer Center, Graz, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Gastroenterology (GU)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved